Injectable and Spatially Patterned Microporous Annealed Particle (MAP) Hydrogels for Tissue Repair Applications. by Darling, Nicole J et al.
UCLA
UCLA Previously Published Works
Title



















eScholarship.org Powered by the California Digital Library
University of California
CommuniCation
1801046 (1 of 8) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
Injectable and Spatially Patterned Microporous Annealed 
Particle (MAP) Hydrogels for Tissue Repair Applications
Nicole J. Darling, Elias Sideris, Naomi Hamada, S. Thomas Carmichael,  
and Tatiana Segura*
Dr. N. J. Darling, E. Sideris, N. Hamada, Prof. T. Segura[+]
Department of Chemical and Biomolecular Engineering
University of California, Los Angeles
420 Westwood Plaza, Los Angeles, CA 90095, USA
E-mail: tatiana.segura@duke.edu
Prof. S. T. Carmichael
Department of Neurology
David Geffen School of Medicine
University of California, Los Angeles
621 Charles Young Drive, Los Angeles, CA 90095, USA
DOI: 10.1002/advs.201801046
surrounding ECM to promote new tissue 
deposition.[3,4] In the brain, injury causes 
not only matrix degradation, but also the 
formation of an impermeable astrocytic 
scar that engulfs the injured area.[5] While 
this prevents further brain damage, it also 
prevents new matrix deposition in this 
area. In an effort to accelerate wound clo-
sure and promote healing in nonhealing 
skin or brain wounds, the field of tissue 
repair has investigated the use of artificial 
ECM matrices, which recapitulate aspects 
of the natural ECM, and can be utilized 
by residing cells as a scaffold for tissue 
growth.[6] The goal is to recapitulate suf-
ficient aspects of the matrix to promote 
tissue repair of such promoting infiltra-
tion of residing cells that can build their 
own native ECM as the temporary syn-
thetic ECM degrades away.
Over the past several decades, poly-
meric hydrogels containing physical and bioactive cues have 
been developed as ECM mimics.[7] Specifically, injectable hydro-
gels which form via a sol–gel transition are highly translatable 
as they can be injected and take on the form of any wound or 
cavity before complete gelation in situ. However, most inject-
able hydrogels are physically and chemically homogeneous, a 
property not observed in the native ECM.[6] Physical or chemical 
gradients are often necessary to recruit cells to a specific loca-
tion like a wound or stroke cavity.[8–11] An Ac-RGDSPGERCG-
NH2 (RGD) gradient has previously been shown to direct cell 
alignment and migration in vitro.[12] Yet the most common 
method of incorporating either a physical or chemical gradient 
in a hydrogel is by using photopolymerization, which results in 
a hydrogel that cannot be injected and is significantly limited 
in its use in the clinic.[13–17] The development of an injectable 
hydrogel with defined gradients still poses a major challenge 
in the field.
We previously engineered the first class of injectable syn-
thetic porous hydrogels, termed microporous annealed particle 
(MAP) hydrogels.[18–20] MAP hydrogels are granular materials 
constructed from micrometer-sized hydrogel particles that are 
annealed to each other postinjection. These granular hydrogels 
contain an interconnected micrometer-sized porous network 
due to the uneven packing of the building blocks. Although 
the use of granular MAP scaffolds in tissue repair and regen-
eration is just beginning, their ability to accelerate wound 
healing[18] and reduce inflammation[19] makes them ideal arti-
ficial ECM scaffolds for tissue repair applications. However, so 
Spatially patterned hydrogels are becoming increasingly popular in the field 
of regenerative medicine and tissue repair because of their ability to guide cell 
infiltration and migration. However, postfabrication technologies are usually 
required to spatially pattern a hydrogel, making these hydrogels difficult to 
translate into the clinic. Here, an injectable spatially patterned hydrogel  
is reported using hyaluronic acid (HA)-based particle hydrogels. These par-
ticle hydrogels are sequentially loaded into a syringe to form a pattern and, 
once injected, they maintain the pattern. The applicability of this hydrogel 
in a wound healing skin model, a subcutaneous implant model, as well as a 
stroke brain model is examined and distinct patterning in all models tested is 
shown. This injectable and spatially patterned hydrogel can be used to create 
physical or biochemical gradients. Further, this design can better match the 
scaffold properties within the physical location of the tissue (e.g., wound 
border vs wound center). This allows for better design features within the 
material that promote repair and regeneration.
Tissue Repair
The extracellular matrix (ECM) is a heterogeneous network 
of biopolymers including complex proteins and sulfated and 
nonsulfated glycosaminoglycans that provide mechanical 
support and organization to the tissue, and spatiotemporal 
presentation of chemical cues.[1] Collectively, these features 
control cell growth, migration, and differentiation, which lead 
to tissue homeostasis. After injury, the ECM is broken down 
by mechanical forces and proteases released by inflammatory 
cells.[2] While in normal skin wound healing, temporary matrix 
degradation ensures that the wound is clean and ready for new 
tissue deposition, in nonhealing chronic wounds, matrix degra-
dation limits the physical and chemical support provided by the 
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far, the building blocks have been uniformly mixed, generating 
a random configuration of building blocks. Herein, we show 
that spatial patterning of granular hydrogel materials can be 
achieved by taking advantage of jammed layered particle struc-
tures, which when injected at appropriate flow rates, retain 
their layered structures after injection and anneal into the sub-
cutaneous space, skin wounds, and brain stroke wounds, dem-
onstrating the versatility of the approach.
Microgel (µgel) hydrogel building blocks with ≈100 µm 
diameter were generated using a flow focusing microfluidic 
device as previously described.[20] µgels were labeled during 
fabrication with three different fluorophores (555, 488, 647 nm 
shown as red, green, white, respectively) such that the layers 
could be visualized with fluorescent confocal microscopy. The 
µgels also contained two peptides which are substrates of 
factor XIIIa (FXIIIa), such that annealing can occur through 
this enzymatic reaction as previously demonstrated.[18–20] We 
first tested if injecting sequential granular MAP scaffolds next 
to each other would allow distinct layers to be formed without 
mixing. In vitro, µgels in equal volumes were injected into a 
poly(dimethyl)siloxane (PDMS) mold (Figure 1A) from left to 
right in rapid succession (green, followed by red, followed by 
far-red µgels). ImageJ analysis confirmed an intensity profile 
from left to right, showing a peak in green pixels first, followed 
by red pixels, and white pixels last, indicating that the µgels 
retain their position after injection. Analysis of the percent of 
each color in each layer reveals that a large majority of µgels 
for each of the layers contained the color injected in that layer, 
with 89% green µgels found in the first layer injected, 80% of 
red µgels found in the second layer injected, and 69% of far-red 
µgels found in the last layer injected. The red region is in equal 
contact with both the green and white regions and was found to 
contain equal percentage of white and green µgels. For both the 
green and far-red regions, very few of the white and green µgels 
were found in each other’s regions because the white and green 
regions are not in contact with each other. These data show that 
in vitro a straight left to right pattern could be achieved through 
sequential injections followed by annealing. This linear pattern 
can be useful in vitro to study cell migration through different 
layers. Further, this strategy of creating layers is not limited to 
just three equal volume layers as more layers can be created.
Next, we tested our patterned hydrogel in an in vivo skin 
wound model. A biopsy punch was used to create a cylindrical 
skin wound on the backs of the mice (≈6 mm diameter × 1 mm 
high). Similar to the sequential injection strategy used to create 
side-by-side layers, here multiple injections were used to create 
a radial pattern. The first layer injected was the outmost layer 
and the last was the center (Figure 1D). Three days post layered 
gel injection, the skin was cut in half and imaged along the 
center using confocal microscopy. As expected, a radial pattern 
could be observed with white µgels on both the ends, red µgels 
adjacent to them, and green µgels in the center. An intensity 
profile from left to right quantitatively defined two white pixel 
peaks on the edges, one green pixel peak in the middle, and 
two red pixel peaks between the white and green peaks. Similar 
to the in vitro data, three clear regions are observed with 88% of 
white, 62% of red, and 69% of green µgels located in the white, 
red, and green regions, respectively (Figure 1E,F). The middle 
region (red µgels) is the most heterogeneous given it is the 
middle layer in contact with both the other regions, the layer 
is still comprised of a majority of red µgels (61.72 ± 18.84%). 
Together, these data show that a radial pattern consisting of 
distinct layers can successfully be achieved in vivo through 
sequential injections of MAP µgels.
For many applications such as injection into the subcuta-
neous space or in the brain, the desired location of the layered 
scaffold is not as easily accessible as it was in the wound healing 
model. For these situations, it is necessary to obtain layers with 
a single injection. We tested our hypothesis that layers of MAP 
µgels could be formed through a single injection if the syringe 
is sequentially loaded with the desired layers. 15 µL of each 
colored particle was sequentially pipetted up to obtain 45 µL of 
total gel in the pipette and then back-loaded into a syringe to 
maintain the same pattern (Figure 2A). A controlled syringe dis-
penser was then used to inject the hydrogel between two cover-
slips from the side, imitating a subcutaneous (Sub-Q) injection 
to obtain a radial pattern. The resulting hydrogel scaffold was 
imaged by confocal microscopy and observed to indeed have 
a radial spatial pattern. Since the white µgels were pulled up 
first, they came out of the syringe last, while the red µgel were 
pulled up last and were the first to come out of the syringe. 
The pattern in Figure 2A shows that the red µgels were radi-
ally “pushed” outward by the green µgels which in turn were 
then radially “pushed” outward by the white µgels, creating 
three distinct layers within a single hydrogel scaffold with little 
mixing between the layers. Although the same volume of each 
color gel was injected, the outer surface occupied by each layer 
is variable, resulting in layers with different thicknesses. If 
equal layer thickness was desired, the volume of each injected 
gel would have to scale with the outer surface area occupied by 
that layer color.
Upon analysis of the various layer distributions using 
ImageJ software analysis (Figure 2B,C), it was found that the 
majority of each colored µgel type was found within its own 
layer, without significant spreading to adjacent layers. Specifi-
cally, 72% of white, 69% of green, and 86% of red µgels were 
found in the white, green, and red layers, respectively. More-
over, it was observed that the majority of mixing occurred from 
the direct neighboring layering. As a result, very few white 
µgels were pushed to the outer red layer and similarly, very few 
red µgels remained in the white region.
Next, to model injection into a stroke cavity, the same two 
coverslip model was used, however, a syringe pump with a 
continuous injection rate of 1 µL min−1 was used to inject the 
hydrogel (a rate previously used in vivo).[19] Here, the green 
µgels exited the syringe first, forming the outer layer, followed 
by the red µgels forming the middle layer, with the white µgels 
exiting last, forming the inner layer (Figure 2D). As before, 
ImageJ software was used to analyze the resulting images 
obtained from confocal imaging. The obtained results were 
improved to those obtained for in vitro subcutaneous injections 
(Figure 2A), showing that using a slower injection rate com-
pared to a bolus injection results in less mixing and stronger 
patterns (Figure 2E,F). It was observed that 83% of white, 80% 
of red, and 91% of green µgels are in the white, red, and green 
regions, respectively. This shows that strong layering can still 
be achieved in the middle layer which is in contact with both 
the inner and outer layers. In fact, decreasing the injection 
Adv. Sci. 2018, 5, 1801046
www.advancedsciencenews.com
1801046 (3 of 8) © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
rate improved the layering in the middle layer from 69.03% to 
79.55% of all red µgels remaining within the middle red layer.
After the in vitro data modeling, a subcutaneous injection 
yielded positive results, we tested our patterned hydrogel in 
vivo. We followed the same procedure to load the syringe as in 
vitro and we injected subcutaneously into a mouse (Figure 3A). 
The skin was collected after three days, fixed using paraform-
aldehyde, and imaged. Here, we did not notice a radial pattern 
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Figure 1. Wound healing in vitro and in vivo in situ patterning. A) Schematic of patterning method pipetting one color µgel at a time into a rectangular 
glass bottom PDMS well. Fluorescent images taken on the Nikon C2 analyzed in ImageJ to generate the intensity profile plot of each color µgel. The 
dashed lines indicate each color region. The numbers indicated the order of injection from the pipette. B) Percent of the total µgels of a given color 
within its respective color region is 74.15%, 72.74%, and 91.33% for white, red, and green, respectively. C) Color region µgel composition is dominated 
by the region color as 68.84%, 80.34%, and 88.59% of white, red, and green µgels within the white, red, and green regions. D) Schematic of patterning 
method pipetting one color µgel at a time, outside to inside, into a 6 mm full thickness dermal wound on the back of a mouse. On day 3, the tissue 
was collected, fixed, cut in half (depicted by the dashed white line), and imaged on the Nikon C2. The intensity profile plot of each color µgel along the 
cross-section was generated. The dashed lines indicate each color region. The numbers indicated the order of injection from the pipette. E) Percent of 
the total µgels of a given color within its respective color region is 74.19%, 67.33%, and 70.97% for white, red, and green, respectively. F) Color region 
µgel composition is dominated by the region color as 88.23%, 61.72%, and 68.69% of white, red, and green µgels within the white, red, and green 
regions. Tukey’s multiple comparison test (p < 0.05). Unless specified otherwise, N = 3.
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Figure 2. In vitro patterning method for Sub-Q injection and PT stroke model. A) Schematic of patterning method by 1) loading the pipette in the order 
indicated by increasing number, 2) back-loading the syringe, which reversed the order of injection, and 3) injecting between two glass slides by repeat-
ably pressing the controlled syringe dispenser. The dashed lines indicate each color region. The numbers indicated the order loaded into the pipette. 
B) Percent of the total µgels of a given color within its respective color region is 83.21%, 62.26%, and 78.53% for white, red, and green, respectively. 
C) Color region µgel composition is dominated by the region color as 71.59%, 86.04%, and 69.03% of white, red, and green µgels within the white, 
red, and green regions. D) Schematic of patterning method using the same steps one and two as in part (A) but injecting between two glass slides 
using a pump at 1 µL min−1. The dashed lines indicate each color region. The numbers indicated the order loaded into the pipette. E) Percent of the 
total µgels of a given color within its respective color region is 80.79%, 76.29%, and 90.67% for white, red, and green, respectively. F) Color region µgel 
composition is dominated by the region color as 83.22%, 91.17%, and 79.55% of white, red, and green µgels within the white, red, and green regions. 
Tukey’s multiple comparison test (p < 0.05). Unless specified otherwise, N = 3. Scale bars = 100 µm.
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like we did in vitro, likely as a result of the angled injection 
into a defined space. However, distinct white, red, and green 
regions could still be observed. Upon analysis of the layers, it 
was similarly shown that 65% of white, 69% of green, and 55% 
of red µgels were found in the white, green, and red layers, 
respectively. (Figure 3B,C). It was also found that in the inner 
white region, the majority of the mixed µgels were from the 
neighboring green region, while in the middle green region, a 
similar number of white and red µgels were found mixed in. 
Finally, in the outer red region, the majority of µgels mixed in 
were from the middle green region, similar to the results found 
in vitro. With these results, we are able to achieve a spatially 
patterned injectable hydrogel with three distinct regions in vivo 
using a subcutaneous implant model.
Finally, we evaluated the in situ patterning in a mouse stroke 
model using a single, controlled injection of multiple MAP sub-
units. A photothrombotic (PT) stroke model to cause ischemia 
in the motor cortex was used to form a stroke cavity. Five days 
post stroke induction, the patterned hydrogel (6 µL total) was 
injected at 1 µL min−1 and allowed to anneal. Two weeks later 
(a time point used previously for tissue analysis[19]), the brains 
were collected for tissue processing and cryosectioning. Each 
brain sample was sectioned until the middle of the stroke 
lesion containing the largest hydrogel cross-sectional area 
could be observed. The remaining brain was imaged under a 
confocal microscope (Figure 3D). Interestingly, unlike what 
was observed for the in vivo subcutaneous injections, a radial 
pattern was observed within the stroke cavity. Once again, 
the layers are of different thicknesses because the same volume 
of each color subunit was injected and in a radial pattern, the 
outer surface area occupied by each layer is different. Distinct 
layering was observed with the inner and middle regions, white 
and green, respectively. The outer red region was more mixed 
containing both red and green µgels. Specifically, 76% of white, 
76% of green, while only 54% of red were observed in the white, 
green, and red regions, respectively (Figure 3E,F). We likely do 
not see as much of a separation of the green and red µgels in 
the green region because of the thinness of the green region. 
Regardless, we do observe excellent layering in the white and 
green regions, and a majority separation in the red region.
Similar to wound healing, we have previously shown that 
MAP gel can reduce inflammation and recruit neural pro-
genitor cells to the stroke. However, the inclusion of a phys-
ical or biochemical pattern to better guide cells to the middle 
of the stroke lesion is predicted to further improve the bio-
logical response and lead to better stroke repair.[19] Here, we 
showed that it is possible to create a pattern using different 
colored MAP subunits with a single injection or by sequential 
injection into an open wound. Given the tenability of these 
subunits, additional studies can evaluate the impact of brain 
regeneration or skin wound healing following stroke using 
various MAP subunits containing different stiffnesses or densi-
ties of peptides (i.e., RGD, etc.) or growth factors (i.e., vascular 
endothelial growth factor (VEGF), brain-derived neurotrophic 
factor (BDNF), etc.) to further guide neuronal or keratinocyte 
cell migration. Stiffness gradients can be created by changing 
the stiffness of each µgel layer which have shown to promote 
cellular migration with various cell types.[21,22] Growth factor 
gradients can similarly be created by encapsulating different 
concentration of growth factor in each layer and also have been 
shown to significantly affect cellular behavior.[23,24]
Here, we engineer MAP hydrogels into injectable, gradient 
hydrogels in the skin and brain. To the best of our knowledge, 
this is the first example of an injectable, porous, gradient 
hydrogel with the potential for use in vivo. It was shown that 
a variety of building blocks can be used to create MAP hydro-
gels and the spatial presentation of the building blocks can be 
controlled to create layers. Both sequential injections and single 
injections can be used to establish gradients of different colored 
MAP subunits in vitro and in three models in vivo, wound 
healing, subcutaneous space, stroke cavity. Only a low degree 
of spreading was observed between adjacent layers, that was 
further improved through controlled injection rates via syringe 
pumps. We believe that this platform can have widespread use 
in the field of regenerative medicine as it can be adapted to 
multiple organs. Moreover, a variety of gradients can be created 
using this hydrogel technique as the MAP subunits are highly 
tunable.
Experimental Section
Hyaluronic Acid Modification: Hyaluronic acid (HA) was functionalized 
with an acrylate group using a previously described two-step reaction.[25] 
Briefly, HA (60 000 Da, Genzyme Corporation, Cambridge, MA) (2.0 g, 
5.28 mmol) was dissolved in water mixed with adipic dihydrazide (ADH, 
18.0 g, 105.5 mmol) with 1-ethyl-3-(dimethylaminopropyl) carbodiimide 
hydrochloride (EDC, 4.0 g, 20 mmol) with pH adjustment to 4.75. 
This mixture reacted overnight to form hydrazide-modified hyaluronic 
acid (HA-ADH). Purification via dialysis (8000 molecular weight 
cut-off (MWCO)) was completed in deionized water for two days. 
The HA-ADH was then flash-frozen and lyophilized. HA-ADH (1.9 g) 
was dissolved in 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid 
(HEPES) buffer (10 × 10−3 m HEPES, 150 × 10−3 m NaCl, 10 × 10−3 m 
ethylenediaminetetraacetic acid (EDTA), pH 7.4) and mixed with 
N-acryloxysuccinimide (NHS-AM, 1.33 g, 4.4 mmol) and reacted 
overnight. Purification via dialysis against deionized water for two days 
was completed, and HA–acrylate was flash-frozen and lyophilized. The 
product was analyzed with 1 H NMR (D20) and the percent modification 
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Figure 3. In vivo patterning method for Sub-Q injection and PT stroke model. A) Schematic of patterning method using the same steps one and two 
as in Figure 2A and then injecting into the subcutaneous layer of the mouse hind skin by repeatably pressing the controlled syringe dispenser. On 
day 3, the tissue was collected and imaged on a glass slide, dermal layer up. The dashed lines indicate each color region. The numbers indicated the 
order loaded into the pipette. B) Percent of the total µgels of a given color within its respective color region is 74.69%, 66.11%, and 46.25% for white, 
red, and green, respectively. C) Color region µgel composition is dominated by the region color as 65.29%, 69.30%, and 54.76% of white, red, and 
green µgels within the white, red, and green regions. D) Schematic of patterning method using the same steps one and two as in Figure 2A and then 
injecting into a PT-stroked mouse at 1 µL min−1. The dashed lines indicate each color region. The numbers indicated the order loaded into the pipette. 
E) Percent of the total µgels of a given color within its respective color region is 87.86%, 60.98%, and 58.42% for white, red, and green, respectively. 
F) Color region µgel composition is dominated by the region color as 76.11%, 54.29%, and 75.90% of white, red, and green µgels within the white, 
red, and green regions. Tukey’s multiple comparison test (p < 0.05). Unless specified otherwise, N = 3. Scale bars = 100 µm.
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(14%) was determined by dividing the multiplet peak at δ = 6.2 (cis and 
trans acrylate hydrogens) by the singlet peak at δ = 1.6 (singlet peak of 
acetyl methyl protons in HA monomer). The HA–acrylate was stored at 
−20 °C until used.
Microfluidic Device Design and Fabrication: Water-in-oil flow focusing 
microfluidic molds were fabricated using soft lithography as previously 
described.[18] In brief, KMPR 1025 or 1050 photoresist (Microchem) 
was used to create master molds on mechanical grade silicon wafers 
(University wafer). Manufacturer’s suggestions were used for spinning 
photoresist to obtain a channel height of 55 µm. PDMS Sylgard 184 kit 
(Dow Corning) devices were made from the master molds. A 10:1 ratio 
of base to cross-linker was used and added over the mold. Once 
degassed, the PDMS cured at 60 °C overnight. A glass microscope 
slide (VWR) and the PDMS molds were treated with oxygen plasma at 
500 mTorr and 75 W for 15 s and pressed together to seal the channels. 
Immediately following channel sealing, Rain-X was infused into the 
device and allowed to react for 20 min at room temperature. The Rain-X 
was aspirated from the channels and the device was allowed to dry by 
air overnight.
HA MAP Gel Formation, Purification, and Annealing: The HA 
microgels were formed using a four inlet, one outlet microfluidic 
device previously reported.[20] Briefly, two inlets were used for the 
“inner pinching” oil (1% v/v span-80 in heavy mineral oil) and “outer” 
oil (5% v/v span-80 in heavy mineral oil), while the other two inlets 
allowed the HA solution and the cross-linker solution to be mixed 
immediately before the “pinching” occurred. The HA solution was 
freshly prepared by first dissolving HA–acrylate in 0.3 m triethanolamine 
(TEOA) pH 8.8 at 7% w/v. This solution was then used to dissolve three 
thiol-containing pendent peptides: K-peptide (Ac-FKGGERCG-NH2), 
Q-peptide (Ac-NQEQVSPLGGERCG-NH2), and RGD at 500 × 10−6, 
500 × 10−6, and 1000 × 10−6 m, respectively. The solution was then 
loaded into the 1 mL Hamilton Gastight Syringe after a 30 min 
incubation at 37 °C to prereact the thiol-containing pendent peptides 
with the HA–acrylate. Meanwhile, the cross-linker solution was prepared 
by dissolving the dithiol matrix metalloproteinase (MMP)-sensitive 
linker peptide (Ac-GCRDGPQGIWGQDRCG-NH2, Genscript) in distilled 
water at 7.8 × 10−3 m followed by reacting with 10 × 10−6 m Alexa-Fluor 
488-maleimide (LifeTechnologies) for green µgels, 10 × 10−6 m Alexa-Fluor 
555-maleimide for red µgels, and 10 × 10−6 m Alexa-Fluor 647-maleimide 
for white µgels for 5 min. The cross-linker solution was then loaded 
into another 1 mL Hamilton Gastight Syringe. Two syringe pumps were 
used to separately control the flow rates of the oils and the gel precursor 
solutions. The gel precursor solutions were coflowed at a 1:1 volume to 
form microgel droplets and left overnight at 25 °C to fully cross-link. The 
final microgel composition was 3.5 wt% HA-AM, 250 × 10−6 m K-peptide, 
250 × 10−6 m Q-peptide, 500 × 10−6 m RGD, 5 × 10−6 m Alexa-Fluor (488, 
555, 647)-maleimide, and 3.9 × 10−3 m cross-linker (thiol:acrylamide 
(AM) is 0.8). The microgels were transferred to microcentrifuge tubes 
and HEPES buffer saline (pH 7.4 containing 10 × 10−3 m CaCl2) was 
added to each tube. The tubes were then centrifuged at 18 000 × g for 
5 min to create a separation between the pelleted microgels and the 
oil and surfactant. The supernatant was aspirated and the procedure 
above was repeated until all the oil and surfactant was removed from 
the microgels (≈6 times). To anneal, pelleted microgels were mixed with 
200 units mL−1 of activated FXIIIa and after injection, were incubated at 
37 °C for 90 min to undergo a transglutaminase reaction between the K 
and Q peptides as previously described.[18]
In Vitro Wound Healing Model: Wound healing model molds were 
created by curing PDMS at 60 °C overnight. 2 cm × 4 cm rectangles 
were cut out of the PDMS and the resulting frames were bonded to a 
glass coverslip using plasma oxygen. 15 µL of green microgels mixed 
with 200 units mL−1 of FXIIIa was injected on one side of the mold. 
Immediately after, 15 µL of red microgels mixed with 200 units mL−1 
of FXIIIa was injected in the middle and then 15 µL of white microgels 
mixed with 200 units mL−1 of FXIIIa was injected on the end. Scaffolds 
were allowed to anneal at 37 °C for 90 min and then imaged using a 
Nikon Ti Eclipse equipped with C2 laser light-emitting diode (LED) 
excitation.
In Vivo Wound Healing Model: Animal procedures were performed 
in accordance with the US National Institutes of Health Animal 
Protection Guidelines and the University of California, Los Angeles 
(UCLA) Chancellor’s Animal Research Committee. CLR:Skh1-Hrhr 
mice (Charles River Laboratories) were anesthetized using aerosolized 
isofluorane (1.5 vol%) throughout the duration of the procedure. The 
skin was disinfected with sequential washes of povidone-iodine and 70% 
ethanol. The mice were placed on their side and dorsal skin was pinched 
along the midline. A sterile 4 mm biopsy punch was used to create two 
clean-cut, symmetrical, full-thickness excisional wounds on either side of 
the dorsal midline. First, 10 µL of red µgels were added to the periphery 
of the skin wound using a positive displacement pipette (Gilson). 
Immediately after, 10 µL of green µgels were added in a circular motion 
inside the outer red layer to form the middle layer. Finally, 10 µL of white 
µgels were added to the center of the wound to form the inside layer. 
The mice were left under anesthesia for another 30 min to allow the 
hydrogel to anneal. Three days later, mice were sacrificed by isofluorane 
overdose and cervical dislocation. The skin samples were retrieved and 
cut in half through the wound and then imaged using a Nikon Ti Eclipse 
equipped with C2 laser LED excitation.
In Vitro Subcutaneous and Stroke Models: To create the molds, one 
2 mm thick spacer was placed on each end of a coverslip. Another 
coverslip was placed on top of the spacers and clipped together using 
a small paper clip on each end. Using a positive displacement pipette 
(Gilson), 15 µL of white µgels were pulled up. The pipette volume was 
then changed to 30 µL and 15 µL of green µgels were pulled up. Finally, 
the pipette volume was changed to 45 µL and 15 µL of red µgels were 
pulled up, resulting in 45 µL of MAP gel in the pipette. Next, the gel was 
transferred to a 100 µL Hamilton Syringe by back-loading to maintain 
the same pattern. For the subcutaneous injections, a controlled syringe 
dispenser (Hamilton) was used to inject the entire 45 µL MAP hydrogel 
between the two coverslips. The resulting MAP gel was allowed to 
anneal at 37 °C for 90 min and then imaged using a Nikon Ti Eclipse 
equipped with C2 laser LED excitation. For the stroke injections, the 
100 µL syringe was loaded onto a Nexus 3000 syringe pump (Chemyx) 
and injected between two coverslips at a 1 µL min−1 injection rate. The 
resulting MAP gel was allowed to anneal at 37 °C for 90 min and then 
imaged using a Nikon Ti Eclipse equipped with C2 laser LED excitation.
In Vivo Subcutaneous Implant Model: All in vivo studies were 
conducted in compliance with the National Institutes of Health(NIH) 
Guide for Care and Use of Laboratory Animals and UCLA ARC  standards. 
Similar to the in vitro procedure, using a positive displacement pipette 
(Gilson), 15 µL of white µgels were pulled up. The pipette volume was 
then changed to 30 µL and 15 µL of green µgels were pulled up. Finally, 
the pipette volume was changed to 45 µL and 15 µL of red µgels were 
pulled up, resulting in 45 µL of MAP gel in the pipette. Next, the gel was 
transferred to a 100 µL Hamilton Syringe by back-loading to maintain 
the same pattern. A controlled syringe dispenser (Hamilton) was used 
to inject the entire 45 µL MAP hydrogel subcutaneously into the mice. 
The mice were left under anesthesia for another 30 min to allow the 
hydrogel to anneal. Three days later, mice were sacrificed by isofluorane 
overdose and cervical dislocation. The skin samples were retrieved and 
imaged using a Nikon Ti Eclipse equipped with C2 laser LED excitation.
In Vivo Photothrombotic Stroke Model: Animal procedures were 
performed in accordance with the US National Institutes of Health 
Animal Protection Guidelines and the University of California 
Los Angeles Chancellor’s Animal Research Committee. A cortical 
photothrombotic stroke was induced on 8–12week male C57BL/6 mice 
obtained from Jackson laboratories (Bar Harbor, ME). The mice were 
anesthetized with 2.5% isoflurane and placed onto a stereotactic setup. 
The mice were kept at 2.5% isoflurane in N2O:O2 for the duration of the 
surgery. A midline incision was made and Rose Bengal (10 mg mL−1, 
Sigma-Aldrich) was injected intraperitoneally at 10 µL g−1 of mouse 
body weight. After 5 min of Rose Bengal injection, a 2 mm diameter 
cold fiberoptic light source was centered at 0 mm anterior/1.5 mm 
lateral left of the bregma for 18 min and a burr hole was drilled through 
the skull in the same location. All mice were given sulfamethoxazole 
and trimethoprim oral suspension (TMS, 303 mL TMS per 250 mL H2O, 
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Amityville, NY) every five days for the entire length of the experiment. 
Using a positive displacement pipette (Gilson), 2 µL of white µgels 
were pulled up. The pipette volume was then changed to 4 µL and 2 µL 
of green µgels were pulled up. The pipette volume was then changed to 
6 µL and 2 µL of red µgels were pulled. This was repeated once more 
to create a total volume of 12 µL. Next, the gel was transferred to a 
25 µL Hamilton Syringe by back-loading to maintain the same pattern. 
Five days poststroke, the Hamilton Syringe containing the patterned gel 
was connected to a pump and 6 µL of MAP was injected into the stroke 
cavity using a 30 gauge needle at a depth of 0.8 mm and the same 
stereotaxic coordinates as above at an infusion speed of 1 µL min−1. 
The needle was withdrawn from the mouse brain 5 min after the 
injection to allow for annealing of the microgels. Ten days postinjection, 
mice were sacrificed via transcardial perfusion of 1× phosphate buffered 
saline (PBS) followed by 40 mL of 4% paraformaldehyde (PFA). The 
brains were isolated and postfixed in 4% PFA overnight and submerged 
in 30% w/v sucrose solution for 48 h. Tangential cortical sections of 
100 µm thickness were sliced using a cryostat until halfway into the 
stroke. The remaining half of the brain was unmounted and imaged 
using a Nikon Ti Eclipse equipped with C2 laser LED excitation.
Image Analysis Using ImageJ Software: All images were analyzed using 
ImageJ software. In each image, three regions were traced to separate 
the white, red, and green regions. Each region was analyzed by obtaining 
the percent area occupied by the white, red, and green µgels. Moreover, 
each µgel color was analyzed to obtain the percent distribution of the 
µgel color in each region.
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